Abstract | BACKGROUND: RESULTS: Once the diagnosis was eventually made, they all had a rapid and excellent response to levodopa, albeit with the early appearance of interdose dyskinesias in 3. CONCLUSIONS: We discuss possible reasons for the missed diagnosis despite the relentless progression of their motor handicap. DAT scanning supported the revised clinical diagnosis of parkinsonism. © 2011 Movement Disorder Society.
|
Authors | Helen Ling, Mark Braschinsky, Pille Taba, Siiri-Merike Lüüs, Karen Doherty, Anna Hotter, Werner Poewe, Andrew J Lees |
Journal | Movement disorders : official journal of the Movement Disorder Society
(Mov Disord)
Vol. 26
Issue 7
Pg. 1337-40
(Jun 2011)
ISSN: 1531-8257 [Electronic] United States |
PMID | 21449012
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Movement Disorder Society. |
Chemical References |
- Antiparkinson Agents
- Levodopa
- Ubiquitin-Protein Ligases
- parkin protein
|
Topics |
- Adult
- Age of Onset
- Antiparkinson Agents
(therapeutic use)
- Delayed Diagnosis
- Diagnosis, Differential
- Dystonic Disorders
(diagnosis)
- Fatigue Syndrome, Chronic
(diagnosis)
- Female
- Gait Disorders, Neurologic
(diagnosis)
- Humans
- Levodopa
(therapeutic use)
- Parkinsonian Disorders
(diagnosis, drug therapy, genetics)
- Time Factors
- Ubiquitin-Protein Ligases
(genetics)
- Young Adult
|